1
Return

Twelve-Month Outcome of Nasolabial Fold Correction by a Novel Non-1,4-Butanediol Diglycidyl Ether, Click-Crosslinked, Long-Chain Hyaluronic Acid Product

delete2026-04-01
delete0
PRE
AI
S
Safir, Ari *
S
Sattler, Sonja
D
Da Mota, Rodrigo
K
Kowalska-Oledzka, Elzbieta
K
Kedar, Daniel J.
G
Gronovich, Yoav
L
Lotan, Adi Maisel
S
Shneider, Svetlana
M
Meunier, Stephane
A
Artzi, Ofir
DOI:10.1111/jocd.70840delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Background Hyaluronic acid (HA) products used for nasolabial fold (NLF) correction are typically crosslinked with 1,4-Butanediol diglycidyl ether (BDDE) and contain high HA concentrations and short HA chains. These characteristics may contribute to increased stiffness, enhanced immune reactivity, and less natural aesthetic outcomes. A novel HA material utilizing click-chemistry for crosslinking to preserve long-chain structure and afford low HA concentration and minimal modification was developed as a potential alternative.Aim The aim of this study was to evaluate the 12-month safety and clinical performance of a non-BDDE, click-chemistry crosslinked, long-chain HA compound (HLR-2, Hallura) for NLF correction.Methods Two prospective, open-label studies were conducted, one in Europe and the other in Israel. All subjects received HLR-2 injections and were followed for 12 months. Efficacy was assessed by the Wrinkle Severity Rating Scale, Global Aesthetic Improvement Scale, and patient satisfaction measures. Safety was monitored through reporting of adverse events (AE) and documentation of injection site reactions (ISR).Results Sixty-two subjects (29 Israeli and 33 European) were included. Responder rates at 6 months were 90.7% and 86.4%, respectively, with improvements sustained throughout 12 months. Satisfaction levels remained high (>= 94% at all time points). ISRs were mild and transient, with no serious or delayed-onset AEs, and favorable induction of collagen and elastin and enhanced tissue integration were documented.Conclusion HLR-2 demonstrated high efficacy, high patient satisfaction, and a favorable safety profile over 12 months. The product's distinctive composition and clinical performance support its use for aesthetic indications, with potential for broader therapeutic applications.
Keywords:
aesthetic medicine
click-chemistry
hyaluronic acid
nasolabial folds
non-BDDE crosslinking
wrinkle correction

Journal

J
Journal of Cosmetic Dermatology
IF:
2.5
Papers:
396
Citations:
9.6K

Organization

S
Sackler Faculty of Medicine
Scholars:
8.7K
Papers: 6.6K
Citations: 4
Shaare Zedek Medical Center cover
Shaare Zedek Medical Center
Scholars:
1.9K
Papers: 1.4K
Citations: 1.8K
T
Tel Aviv Sourasky Medical Center
Scholars:
289
Papers: 132
Citations: 0
T
tel aviv university
Scholars:
4.8K
Papers: 1.8K
Citations: 1
Cited Papers

Cited Papers

Citing Papers

Citing Papers